Roble Belko & Company’s Steris STE Stock Holding History

Roble Belko & Company’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-78	Closed	-$5K	–	345
2017 Q1	$5K	Hold	78	–	–	﹤0.01%	262
2016 Q4	$5K	Buy	+78	New	+$5.29K	﹤0.01%	275

Other funds holding STE

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Roble Belko & Company's STE Position: Q2 2017 in Review

Roble Belko & Company sold out of Steris (STE) in Q2 2017, closing a stake of 78 shares — an estimated $5K sold.

Roble Belko & Company first reported a position in STE in Q4 2016 and held it in 2 quarters. The position peaked at $5K in Q1 2017. 297 funds tracked by Wall St. Rank hold STE as of Q2 2017.

Roble Belko & Company reported no remaining Steris position as of Q2 2017 after selling out during the quarter.
Roble Belko & Company sold 78 Steris shares in Q2 2017, an estimated $5K.
Roble Belko & Company first reported a position in Steris in Q4 2016 and held it in 2 quarters.
Roble Belko & Company's Steris position peaked at $5K in Q1 2017.
297 funds tracked by Wall St. Rank held Steris as of Q2 2017.

Based on Roble Belko & Company's 13F filing for Q2 2017, filed 11 Aug 2017.